Three Biotech Investment Ideas from Cormorant Asset Management
The biotech industry is regaining ground it lost in 2016 at full speed.
Posts Tagged ‘Bihua Chen’
Sunesis Pharmaceuticals Inc (SNSS): Cormorant Asset Management Reports New 5.14% Stake
Sunesis Pharmaceuticals Inc (NASDAQ:SNSS) has a new shareholder in the form of Bihua Chen's Cormorant Asset Management.
Myokardia Inc (MYOK): Cormorant Asset Management Raises Its Stake
A recent 13G filing with the Securities and Exchange Commission revealed that Bihua Chen's Cormorant Asset Management has boosted its stake in Myokardia Inc (NASDAQ:MYOK) to ...
Cormorant Asset Management Doesn’t Think Corbus Pharmaceuticals Holdings Inc. (CRBP) Is Done Soaring Just Yet
In a new 13G filing with the SEC, Bihua Chen's Cormorant Asset Management reported owning 2.35 million shares of Corbus Pharmaceuticals Holdings Inc.
Gemphire Therapeutics Inc. (GEMP): Cormorant Asset Management Reports New Stake
According to a new 13G filing with the Securities and Exchange Commission, Bihua Chen's Cormorant Asset Management owns 900,000 shares of Gemphire Therapeutics Inc.
Clearside Biomedical Inc (CLSD): Cormorant Reveals 10.1% Stake
Bihua Chen's Cormorant Asset Management has revealed a position in Clearside Biomedical Inc (NASDAQ:CLSD), through a 13G filing issued with the SEC yesterday.
Quotient Ltd (QTNT): Bihua Chen’s New Fund, Cormorant Asset Management, Triples Stake
Bihua Chen’s Cormorant Asset Management disclosed, last Thursday, that it had tripled its exposure to Quotient Ltd (NASDAQ:QTNT), from 500,000 shares held by the end of the ...
